About Long Le, MD, PhD
Dr. Long Phi Le is a graduate of Massachusetts Institute of Technology (1999) and received his MD and PhD from the University of Alabama at Birmingham School of Medicine in 2006. He completed his residency training in Clinical Pathology at the Massachusetts General Hospital and his Molecular Genetic Pathology Fellowship at Brigham and Women's Hospital (2010). He joined the Mass General Pathology Department in 2010. His clinical and research interests in the Center for Integrated Diagnostics (formerly the Diagnostic Molecular Pathology Laboratory) include the application of copy number analysis, next generation sequencing, and bioinformatics in molecular diagnostics.
Clinical Interests:
- Molecular pathology
Treats:
- Adult
Languages:
- Vietnamese
Locations
Mass General Pathology
55 Fruit St.
Boston, MA 02114
Phone: 617-643-0800
Medical Education
- M.D.; Ph.D., University of Alabama School of Medicine
- MD, University of Alabama, Birmingham
- Residency, Massachusetts General Hospital
- Residency, Massachusetts General Hospital
- Fellowship, Brigham & Women's Hospital
- Fellowship, Brigham and Women's Hospital
American Board Certifications
- Clinical Pathology, American Board of Pathology
- Molecular Genetic Pathology, American Board of Pathology
Accepted Insurance Plans
- Aetna
- Beech Street
- Blue Cross Blue Shield
- Blue Cross Blue Shield Medicare
- Cigna
- Commonwealth Care Alliance
- Coventry
- Fallon Health
- Harvard Pilgrim Health Care
- Humana
- Maine Community Health Options
- Mass General Brigham Health Plan
- MassHealth
- Medicaid ME
- Medicaid NH
- Medicaid RI
- Medicaid VT
- Medicare
- Medicare ACO
- Multiplan
- Railroad Medicare
- Senior Whole Health
- TriCare
- Tufts Health Plan
- United Health Care
- Wellpoint
- WellSense
- WellSense NH
Note: This provider may accept more insurance plans than shown; please call the practice to find out if your plan is accepted.
Research
For information about research concepts, publications, and co-authors visit Dr. Le???s research profile at the Harvard Clinical and Translational Science Center.
Publications
-
- Inconsistency and features of single nucleotide variants detected in whole exome sequencing versus transcriptome sequencing: A case study in lung cancer. O'Brien TD, Jia P, Xia J, Saxena U, Jin H, Vuong H, Kim P, Wang Q, Aryee MJ, Mino-Kenudson M, Engelman JA, Le LP, Iafrate AJ, Heist RS, Pao W, Zhao Z. Methods. 2015 Apr 23
- GUIDE-seq enables genome-wide profiling of off-target cleavage by CRISPR-Cas nucleases. Tsai SQ, Zheng Z, Nguyen NT, Liebers M, Topkar VV, Thapar V, Wyvekens N, Khayter C, Iafrate AJ, Le LP, Aryee MJ, Joung JK. Nat Biotechnol. 2015 Feb
- Molecular classification of MYC-driven B-cell lymphomas by targeted gene expression profiling of fixed biopsy specimens. Carey CD, Gusenleitner D, Chapuy B, Kovach AE, Kluk MJ, Sun HH, Crossland RE, Bacon CM, Rand V, Dal Cin P, Le LP, Neuberg D, Sohani AR, Shipp MA, Monti S, Rodig SJ. J Mol Diagn. 2015 Jan
- Anchored multiplex PCR for targeted next-generation sequencing. Zheng Z, Liebers M, Zhelyazkova B, Cao Y, Panditi D, Lynch KD, Chen J, Robinson HE, Shim HS, Chmielecki J, Pao W, Engelman JA, Iafrate AJ, Le LP. Nat Med. 2014 Dec